Quick Answer
ADIAL PHARMACEUTICALS, INC. reported Net Income of -$7.98 million for fiscal year 2025.
ADIAL PHARMACEUTICALS, INC. Net Income — Annual History
| Fiscal Year | Net Income | YoY Change |
|---|---|---|
| 2025 | -$7.98M | +39.6% |
| 2024 | -$13.20M | -157.6% |
| 2023 | -$5.12M | +59.8% |
| 2022 | -$12.73M | +34.5% |
| 2021 | -$19.42M | -78.3% |
| 2020 | -$10.89M | -26.8% |
| 2019 | -$8.59M | +26.1% |
| 2018 | -$11.63M | -920.8% |
| 2017 | -$1.14M | — |
Quarterly Net Income
| Quarter Ending | Net Income | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | -$1.79M | +18.2% | +8.4% |
| June 30, 2025 | -$1.96M | +20.3% | +12.1% |
| March 31, 2025 | -$2.23M | +65.6% | -1.7% |
| September 30, 2024 | -$2.19M | -58.3% | +10.8% |
| June 30, 2024 | -$2.46M | -326.0% | +62.0% |
| March 31, 2024 | -$6.48M | -122.9% | -367.6% |
| September 30, 2023 | -$1.38M | +55.5% | -227.3% |
| June 30, 2023 | $1.09M | +128.3% | +137.4% |
- ADIAL PHARMACEUTICALS, INC. showed an increase of +39.6% in Net Income compared to the prior fiscal year.
- Over the 2017–2025 period, ADIAL PHARMACEUTICALS, INC.’s net income has declined by 600.1% (from -$1.14 million to -$7.98 million).
- The most recent figure is from ADIAL PHARMACEUTICALS, INC.’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 5, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: